|
GTF2F2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.54120002607783E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.89290000130305E-08 |
| Normal-vs-Stage2 |
2.424000E-03 |
| Normal-vs-Stage3 |
1.381920E-02 |
| Normal-vs-Stage4 |
2.973000E-04 |
| Stage1-vs-Stage2 |
3.389800E-01 |
| Stage1-vs-Stage3 |
3.271200E-01 |
| Stage1-vs-Stage4 |
5.426000E-01 |
| Stage2-vs-Stage3 |
1.614400E-01 |
| Stage2-vs-Stage4 |
7.865000E-01 |
| Stage3-vs-Stage4 |
3.249400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.16799999672068E-08 |
| Normal-vs-AfricanAmerican |
6.87590000048033E-07 |
| Normal-vs-Asian |
8.324200E-02 |
| Caucasian-vs-AfricanAmerican |
5.895200E-01 |
| Caucasian-vs-Asian |
4.437800E-01 |
| AfricanAmerican-vs-Asian |
3.835000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.59890000525931E-08 |
| Normal-vs-Female |
5.19659999476119E-08 |
| Male-vs-Female |
1.234190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.75119999999263E-05 |
| Normal-vs-Extreme_Weight |
1.17639999963615E-07 |
| Normal-vs-Obese |
5.43339999659054E-08 |
| Normal-vs-Extreme_Obese |
6.793800E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.217000E-01 |
| Normal_Weight-vs-Obese |
1.347410E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.337200E-01 |
| Extreme_Weight-vs-Obese |
2.551600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.966400E-01 |
| Obese-vs-Extreme_Obese |
5.345200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.639900E-04 |
| Normal-vs-Age(41-60Yrs) |
2.20639995163197E-09 |
| Normal-vs-Age(61-80Yrs) |
1.04139999956843E-07 |
| Normal-vs-Age(81-100Yrs) |
1.797790E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.806600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.842800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.962400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.386800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.873800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.975360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.84369963740494E-10 |
| Normal-VS-Type2 PRCC |
1.355890E-02 |
| Normal-VS-KIRP CIMP |
5.389900E-02 |
| Normal-VS-Unclassified PRCC |
4.28500000000387E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.86740000000163E-05 |
| Type1 PRCC-VS-KIRP CIMP |
5.522800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.509000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.993650E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.975500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.677200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.502900E-03 |
| Normal-vs-N1 |
5.93179999999194E-05 |
| Normal-vs-N2 |
2.085000E-01 |
| N0-vs-N1 |
1.321990E-02 |
| N0-vs-N2 |
8.821800E-01 |
| N1-vs-N2 |
2.304000E-01 |
|
|
